The Medicines Company Announces Proposed Public Offering of 5.5 Million Shares of Common Stock

By: Benzinga
The Medicines Company (NASDAQ: MDCO ) today announced that it has commenced an underwritten public offering of up to 5,500,000 shares of its common stock. All of the shares in the offering are to be sold by The Medicines Company. J.P. Morgan Securities LLC and BofA Merrill Lynch are
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.